As of 2025-07-06, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is -4.82 USD. This ALDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.30 USD, the upside of Aldeyra Therapeutics Inc is -212.01%.
Based on its market price of 4.30 USD and our intrinsic valuation, Aldeyra Therapeutics Inc (ALDX) is overvalued by 212.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.82 - -4.82 | -4.82 | -212.01% |
| P/E | (9.88) - (17.97) | (12.91) | -400.2% |
| DDM - Stable | (8.49) - (26.59) | (17.54) | -507.9% |
| DDM - Multi | (7.35) - (18.21) | (10.51) | -344.5% |
| Market Cap (mil) | 257.57 |
| Beta | 2.60 |
| Outstanding shares (mil) | 59.90 |
| Enterprise Value (mil) | 222.32 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.60% |
| Cost of Debt | 5.00% |
| WACC | 9.28% |